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TDP-43 (TAR DNA binding protein of 43kDa) and its C-terminal fragments are thought to be linked to
the pathologies of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Here, we
demonstrate that the aggregates or inclusions formed by its 35-kDa fragment (namely TDP-35)
sequester full-length TDP-43 into cytoplasmic inclusions; and this sequestration is mediated by
binding with RNA that is enriched in the cytoplasmic inclusions. RNA recognition motif 1 (RRM1)
of TDP-43/TDP-35 plays a dominant role in nucleic-acid binding; mutation in this moiety abrogates
formation of the TDP-35 inclusions and its RNA-assisted association with TDP-43. Thus, TDP-35 is
able to sequester TDP-43 from nuclear localization into cytoplasmic inclusions, and RNA binding
plays an essential role in this process.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
TAR DNA binding protein of 43kDa (TDP-43) is a
multi-functional RNA binding protein that is genetically and
pathologically linked to neurodegenerative diseases including
amyotrophic lateral sclerosis (ALS) and frontotemporal lobar
degeneration (FTLD) [1,2]. Ubiquitination, mislocalization, frag-
mentation and aggregation of TDP-43 in cytoplasm are the remark-
able features in these neurodegenerative diseases [2–4]. In ALS and
FTLD patients, the TDP-43-positive inclusions have been found to
co-localize with stress granule markers [5], while in cultured cells
TDP-43 can be directed into stress granules when cells are exposed
to stimuli such as heat shock and oxidative stress [6–8]. These
ribonucleoprotein (RNP)-containing stress granules are transientcytoplasmic structures that are assembled by RNPs and RNAs
[9,10].
TDP-43 strongly associates with RNA splicing and translation
machineries [11]; and binds thousands of RNA targets including
neuronal-speciﬁc RNAs implicated in neurodegenerative disorders
[12,13]. TDP-43 harbors two RNA recognition motifs (RRMs) that
are responsible for binding with DNA and RNA targets. The RRM1
domain is essential for binding to single-strand RNA with six UG
repeats [14], whereas the function of RRM2 is obscure since it is
dispensable for binding to UG repeats [15]. The RNA binding ability
is important for TDP-43 shuttling [16] and inclusion formation
[17–19], but the mechanism by which the RNA exerts functions
in formation of inclusions is largely unknown.
The pathologically derived C-terminal fragments (CTFs) of
TDP-43, including TDP-35 (35kDa), TDP-25 (25kDa) and other
fragments [2,3], have been substantially explored and identiﬁed as
factors triggering cytoplasmic inclusions in cell lines [4,20–22].
Derived from TDP-43 by deletion of its N-terminus, C-terminal frag-
ment of 35kDa (TDP-35) is present predominantly in cytoplasm
co-localizing with stress granule markers [5,23], and forms aggre-
gates or inclusions that lead to alteration of RNA processing [4]. As
a fragment of TDP-43 still containing RNA-binding domains,
TDP-35 is implicated in association with various RNA species that
may confer alternative function of TDP-35 in cytoplasm.
We have investigated the RNA binding abilities of the RRM
domains of TDP-43 or TDP-35. In this communication, we report
that binding with RNA is beneﬁcial to formation of the TDP-35
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inclusions, but also responsible for the sequestration of
full-length TDP-43 into cytoplasmic inclusions by TDP-35.
2. Materials and methods
2.1. Construction of plasmids
Full-length TDP-43 was ampliﬁed via PCR from cDNA library of
HEK 293T cell, and cloned into pcDNA3.0/HA (Invitrogen) by using
BamHI/XholI cloning sites. TDP-35 (residues 90–414) and TDP-25A
(184–414) were constructed into pcDNA3.0/FLAG plasmid
(Invitrogen). The cDNA encoding the tandem RRM domains
(RRM12, residues 101–260) was cloned into pET22b+ expression
vector (Novagen) by using NdeI/XholI cloning sites. The coding
sequence for TDPCT (residues 253–414) was ampliﬁed via PCR
and cloned into pEGFP-C1 to get a GFP-fused protein
(GFP-TDPCT). The mutants (M1, F147/149L; M2, F229/231L; 4FL,
F147/149/229/231L) in TDP-35 and in tandem RRM12 were pre-
pared by PCR site-directed mutagenesis. All constructs were vali-
dated by DNA sequencing. The primers used for ampliﬁcation
and mutagenesis were as follows:TDP-43: 50-AGAGGATCCATGTCTGAATATATTCGGGTAAC-30 (F);
50-AGACTCGAGCTACATTCCCCAGCCAGAAGA-30 (R).TDP-35: 50-AGACTCGAGCTACATTCCCCAGCCAGAAGA-30 (F);
50-AGAGGATCCGCTTCATCAGCAGTGAAAG-30 (R).TDP-25A: 50-AGAGGATCCCAAGATGAGCCTTTGAG-30 (F);
50-AGAGGATCCGCTTCATCAGCAGTGAAAG-30 (R).TDPCT: 50-AGACTCGAGATCAGCGTTCATATATCC-30 (F);
50-AGAGGATCCCTACATTCCCCAGCCAGAAGA-30 (R).F147/149L: 50-GGTCATTCAAAGGGGTTAGGCTTAGTTCGTTTTACGG-30 (F);
50-CCGTAAAACGAACTAAGCCTAACCCCTTTGAATGACC-30 (R).F229/231L: 50-AAGCCATTCAGGGCCCTTGCCCTTGTTACATTTGCAG-30 (F);
50-CTGCAAATGTAACAAGGGCAAGGGCCCTGAATGGCTT-30 (R).2.2. Cell culture, transfection and Western blotting
HEK 293T cells were cultured at 37 C in Dulbecco’s modiﬁed
Eagle’s medium/Ham’s F-12 (Invitrogen) supplemented with 10%
fetal bovine serum (FBS) (Hyclone), penicillin and streptomycin,
and grown at 37 C under a humidiﬁed atmosphere containing
5% CO2. The cells were transfected with plasmids by poly-Jet
(SignaGen Laboratories) or FuGENE HD (Promega) reagent follow-
ing the manufacturer’s instructions, and then harvested at 48 h
post-transfection and lysed in PEB buffer (100 mM KCl, 5 mM
MgCl2, 10 mM HEPES, pH 7.0, 1 mM DTT, 0.5% NP-40, 1 mM
PMSF, cocktail protease inhibitor (Roche)). Samples were cen-
trifuged to separate the supernatant and pellet fractions and sub-
jected to SDS–PAGE with 12% acrylamide gel and transferred
onto a PVDF membrane (PerkinElmer). The indicated proteins were
detected with the following primary antibodies: mouse mono-
clonal antibodies against HA (Sigma), FLAG (Sigma), TDP-43
(Abnova); and goat anti-actin (Santa Cruz). The goat anti-mouse
IgG-HRP antibody, goat anti-rabbit IgG-HRP and rabbit anti-goat
IgG-HRP secondary antibodies (Jackson Immuno-Research) were
also used. The proteins were detected by an ECL detection kit
(Amersham Pharmacia Biotech).
2.3. Immunoprecipitation, immunocytochemistry and confocal
microscopy
HEK 293T cells were lysed in PEB buffer for 30 min on ice, and
then the lysates were incubated with an antibody against FLAG for1 h at 4 C. After incubation, the protein A/G beads (GE Healthcare)
and/or RNase A (Invitrogen) plus single-strand DNA (ssDNA, TG
repeat, 59-nt) were added for another 4 h at 4 C. The beads were
washed with lysis buffer for three times, and the precipitated pro-
teins were subjected to immunoblotting analysis. Similar experi-
ment with DNase (RNase free, Invitrogen) treatment was also
performed. For immunocytochemistry, HEK 293T cells grown and
transfected on cover slides were washed with PBS buffer and ﬁxed
with 4% paraformaldehyde for 10 min and permeabilized with 0.1%
Triton X-100 for 1 min, and then blocked with 5% BSA/1% FBS for
1 h at room temperature. The ﬁxed cells were incubated for 1 h
at room temperature with a monoclonal antibody against FLAG
(Sigma) or combined with antibody against HA (Sigma). After
washing with PBS, the cells were labeled with a secondary
FITC-conjugated anti-mouse antibody (Jackson Immuno-
Research). The nuclei were stained with DAPI (Sigma).The cells
were imaged with a Leica TCS SP2 confocal microscope (Leica
Microsystems).
2.4. Combined ﬂuorescent in situ hybridization (FISH) and
immunoﬂuorescence (IF)
The imaging for RNA/protein was carried out following a litera-
ture with minor modiﬁcations [24]. Brieﬂy, HEK 293T cells (70–
80% conﬂuent) on cover slides were washed with 1 PBS (Sigma)
and ﬁxed with 2% formaldehyde (Bio-Rad) for 10 min and perme-
abilized with 0.5% Triton X-100 (Roche) for 5 min at 4 C, and then
blocked with 3% BSA in 4 SSC (Bio-Rad) at 42 C for 20 min. The
cells were incubated for 1 h at 42 C in dark with different
20-F-modiﬁed oligonucleotides in a hybridization buffer (10% dex-
tran sulfate (Santa Cruz) in 4 SSC), and washed continuously with
washing buffer I (4 SSC, 0.1% Tween-20), II (2 SSC), III (1 SSC)
in dark at 42 C and 1 PBS at room temperature. The probes
(Sangon, Shanghai) were used as follows:
Cy3-28S: Cy3-50-CGA⁄GGGCAA⁄CGGAGG⁄CCA⁄C-30; Cy3-polyT:
Cy3-50-TTT⁄TTTTTTTT⁄TTTTTT⁄TTTTTTTT⁄TTTTTT⁄T-30. Where ‘‘⁄’’
denotes the nucleotide substituted with 20-F-modiﬁed RNA resi-
due. The immunoﬂuorescence experiment was carried out as pre-
viously described but under a condition of light protection.
2.5. Isothermal titration calorimetry (ITC)
His6-tagged wild-type and mutant RRM12 proteins were
expressed in Escherichia coli BL21 (DE3) cells and puriﬁed through
a Ni2+-NTA column (Qiagen) according to manufacturer’s instruc-
tions. These proteins were further puriﬁed by a Superdex-75 col-
umn (GE Healthcare), and the concentrations were determined
spectrophotometrically with a coefﬁcient of 15720 cm1 M1 at
280 nm. The ITC experiments were performed on a MicroCal
iTC200 at 25 C in an ITC buffer (50 mM Tris–Cl, 5 mM MgCl2,
2 mM DTT, pH 8.0) [25]. A protein stock (200 lM) in the syringe
was injected into an ssDNA sample (20 lM). The binding afﬁnities
were calculated by ﬁtting the data with a one-site binding model
using Origin 7.0 software (OriginLab Corp.). The sequences of the
synthesized ssDNAs were as follows: (TG)6, 50-TGTGTGT
GTGTG-30; (CA)6, 50-CACACACACACA-30; (NN)6, 50-NNNNNNNNN
NNN-30 (N stands for any deoxyribonucleotide).
2.6. Supernatant/pellet fractionation and ﬁlter trap analysis
The transfected cells were lysed in 100 lL of a RIPA buffer
(50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP-40,
cocktail protease inhibitor (Roche Applied Science)) on ice for
0.5 h and centrifuged at 16200g for 15 min. The supernatant
was added with 100 lL of the loading buffer (2% SDS), while the
pellet was sufﬁciently washed with the RIPA buffer for three times
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volumes of the supernatant and pellet fractions were subjected
to SDS–PAGE (12% acrylamide gel) and Western blotting with indi-
cated antibodies. The ﬁlter-trap assay was performed as previously
reported to detect protein aggregates in cell lysates [26]. Cells were
lysed with the RIPA buffer on ice for 30 min and centrifuged at
12000 rpm for 10 min, and each 20 lL of the supernatant was
added with equal volume of the loading buffer (2% SDS) for SDS–
PAGE. The cell lysates were mixed with equal volume of the
non-SDS buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1 mM
EDTA, 100 mM DTT) or 4%-SDS buffer at room temperature for
30 min. The SDS-treated samples were further boiled for 5 min.
After centrifugation at 12000 rpm for 5 min, the supernatant was
ﬁltrated by a cellulose acetate membrane (0.2 lm, Whatman).
The membrane was washed twice with the non-SDS buffer and
blotted with an antibody against green ﬂuorescent protein (GFP)
or FLAG.
3. Results
3.1. The TDP-35 inclusions sequester full-length TDP-43 through RNA
Our previous work demonstrated that the 35-kDa fragment of
TDP-43 (TDP-35) forms cytoplasmic aggregates or inclusions that
can sequester full-length TDP-43 [4]. By staining the HEK 293T
cells co-transfected with FLAG-tagged TDP-35 and HA-tagged
TDP-43, we observed that TDP-43 co-localized with theFig. 1. TDP-35 inclusions sequester TDP-43 via RNA in cell. (a) Co-IP experiment exam
immunoprecipitated with a FLAG antibody under various conditions as indicated: non-
without FLAG antibody. The immunoblotting was carried out with an antibody against ei
(b) Co-IP for association of TDP-35 or TDP-25A with endogenous TDP-43. The lysates wit
FLAG antibody under the non-treatment condition and then immunoblotted with an an
lysates were subjected to RNase-A digestion and immunoprecipitated with a FLAG antibo
antibodies. (d) Co-IP experiment examining effect of DNase treatment on the associatiocytoplasmic inclusions formed by TDP-35 (data not shown), as in
the case of the previous observation [4]. As known, the
N-terminal domain of TDP-43 may contribute to the dimerization
or oligomerization of TDP-43 [27,28]. Because TDP-35 has this
N-terminus deleted, it is unlikely that there exists direct protein–
protein interaction between TDP-35 and TDP-43. So we investi-
gated whether other factors are involved in their association.
Since TDP-43 is an RNA-binding protein [29] and RNA binding
maymediate many functions in cell, we performed immunoprecip-
itation andWestern blotting analysis on lysates of the cells overex-
pressed with both FLAG-TDP-35 and HA-TDP-43. Without RNase-A
digestion, a weak band appeared in gel, indicative of HA-TDP-43
precipitated by FLAG-TDP-35 (Fig. 1a, lane 2). When the cell lysates
were subjected to RNase-A treatment, the band was disappeared
(Fig. 1a, lane 5), but it was able to be restored by adding synthe-
sized single-strand DNA (ssDNA) (Fig. 1a, lane 8). This indicates
that RNA is directly involved in the association of TDP-35 with
TDP-43, implying that other RNA binding proteins may be incorpo-
rated in the aggregates or inclusions formed by TDP-35 via various
types of RNA.
We also tested whether TDP-35 associates with endogenous
TDP-43. The data exhibited that FLAG-TDP-35 could immunopre-
cipitate the endogenous TDP-43 (Fig. 1b, lane 2), whereas
TDP-25A [4], another pathological fragment of TDP-43 (25kDa,
residues 184–414) that contains only RRM2 domain (See Fig. 2a),
could not associate with TDP-43 (Fig. 1b, lane 5). The restoration
experiments by adding ssDNA in the RNase-A treated sampleining association of TDP-35 with TDP-43. The lysates from transfected cells were
treatment, RNase-A treatment, or RNase-A plus ssDNA treatment. Con, control, IP
ther HA or FLAG. ssDNA, single-strand DNA (TG repeat, 59-nt); ⁄, heavy chain of IgG.
h overexpressed FLAG-tagged TDP-35 or TDP-25A were immunoprecipitated with a
tibody against either TDP-43 or FLAG. (c) Co-IP for ssDNA-assisted association. The
dy in the presence or absence of ssDNA, and then immunoblotted with the indicated
n of TDP-35 with TDP-43. RNase-A treatment as a control. ⁄, heavy chain of IgG.
Fig. 2. Both RRM domains of TDP-35 are required for association with TDP-43. (a) Schematic representation of the domains in TDP-43 and its fragments, and the point
mutations for the experiments. NT, the N-terminal domain; CT, the C-terminal domain; RRM, RNA recognition motif. TDP-35, residues 90–414; TDP-25A, 184–414; TDPCT,
253–414. The three TDP-35 mutants are: M1, F147/149L; M2, F229/231L; 4FL, F147/149/229/231L. (b) Co-IP experiment examining association of various TDP-35 with TDP-
43. The lysates from HEK 293T cells transfected with FLAG-tagged TDP-35 or its mutants were immunoprecipitated with a FLAG antibody in the presence of RNase A and
ssDNA, followed by immunoblotting with an antibody against either TDP-43 or FLAG.
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TDP-35 with TDP-43 (Fig. 1c, lane 5), but it failed to act on TDP-25A
with TDP-43 (Fig. 1c, lane 11). To test whether DNA was involved
in the association, we conducted immunoprecipitation on the cell
lysates treated with deoxyribonuclease (DNase). Compared with
RNase-A treatment, DNase treatment did not affect sequestration
of TDP-43 by TDP-35 inclusions (Fig. 1d, lane 8). Altogether, these
results demonstrate that sequestration of full-length TDP-43 by
the cytoplasmic TDP-35 inclusions is mediated by RNA.
3.2. Mutation in the RRM domains abolishes the RNA-assisted
association
To further conﬁrm that RNA is essential for the association of
TDP-35 with TDP-43 in cell, we prepared three RNA-binding deﬁ-
cient mutants of TDP-35, including M1 (F147/149L in RRM1), M2
(F229/231L in RRM2) and 4FL (F147/149/229/231L) (Fig. 2a) [29].
Co-immunoprecipitation experiments were carried out on the
lysates from HEK 293T cells overexpressed with wide-type
TDP-35 or its mutants in the presence of ribonuclease A (RNase
A) and ssDNA. The results showed that mutation in the RRM1
region (M1) of TDP-35 considerably reduced the association effect
of TDP-35 with TDP-43 (Fig. 2b, lane 6) as compared with
wild-type TDP-35, whereas mutation in RRM2 (M2) resulted in
undetectable change in immunoprecipitated TDP-43 (Fig. 2b, lane
7). The double mutation both in RRM1 and RRM2 regions com-
pletely abolished the association of TDP-35 with TDP-43 (Fig. 2b,
lane 8), possibly due to abrogation of its binding ability to
ssDNA. This suggests that the RRM1 domain is more important
for TDP-35 binding with TG-repeat DNA or UG-repeat RNA, but
RRM2 is also structurally involved in binding with RNA, which is
consistent with the previous observation [14].3.3. RRM1 plays a dominant role in nucleic-acid binding
TDP-43 contains two RRM domains that can bind RNA as well
as DNA [30]. So ssDNA can be applied to study the nucleic-acid
binding abilities of the RRM domains in vitro, and thus the data
may reﬂect the RNA binding properties of TDP-43 in cell. We
examined the nucleic-acid binding properties of RRM1 and
RRM2 in the context of tandem RRM domains (RRM12) with dif-
ferent types of ssDNA by using ITC method. We puriﬁed four tan-
dem RRM12 domain proteins, including wide-type RRM12, RRM1
2-M1 (F147/149L), RRM12-M2 (F229/231L), and RRM12-4FL
(F147/149/229/231L). The data indicated that RRM12 could not
bind single-strand (CA)6 DNA (a negative control) (Fig. 3a), but
it bound to (TG)6 with an afﬁnity (KD) of 0.30 lM (Fig. 3b), which
is consistent with the previous report [29]. (NN)6 denotes a mix-
ture of random synthesized 12-nt ssDNA; it may mimic the RNA
repertoire in cells. RRM12 bound with (NN)6 with an average
afﬁnity of 36 lM (Fig. 3c), providing a possibility that TDP-43
binds with other RNA sequences. Then we determined the bind-
ing afﬁnities of RRM12 mutants with (TG)6 and (NN)6 DNAs.
Mutation in the RRM1 moiety of RRM12 signiﬁcantly reduced
the binding afﬁnity to a KD of 4.3 lM (Fig. 3d), whereas mutation
in RRM2 only slightly affected the binding afﬁnity with (TG)6
(KD = 0.54 lM) (Fig. 3e). Furthermore, mutation in the two RRM
domains (4FL) completely abolished the binding of RRM12 with
(TG)6 (Fig. 3f). However, each mutation abolished the binding
ability with (NN)6 to a different extent (Fig. 3g–i). These data,
consistent with those from co-immunoprecipitation (Fig. 2b),
demonstrate that RRM1 is indispensable for TDP-43 or TDP-35
binding with nucleic acids, while RRM2 is also contributable to
the binding by cooperatively enhancing the binding afﬁnity of
RRM12 [30].
Fig. 3. ITC analysis for interactions of various RRM12 mutants of TDP-43 with single-strand DNA chains. (a) Titration of wild-type RRM12 with (CA)6. (b) As in (a), with (TG)6.
(c) As in (a), with (NN)6. (d) Titration of the M1 mutant (F147/149L) of RRM12 with (TG)6. (e) As in (d), the M2 mutant (F229/231L). (f) As in (d), the 4FL mutant (F147/149/
229/231L). (g) Titration of the M1 mutant (F147/149L) of RRM12 with (NN)6. (h) As in (g), the M2 mutant (F229/231L). (i) As in (g), the 4FL mutant (F147/149/229/231L). Data
were ﬁtted with one-site binding model. The concentrations of ssDNAs were 20 lM and those of RRM12 stocks were 200 lM.
1924 M.-X. Che et al. / FEBS Letters 589 (2015) 1920–19283.4. RNA binding is responsible for formation of the TDP-35 inclusions
To understand the role of RNA in the inclusion formation of
TDP-35, we performed immunoﬂuorescence imaging on various
FLAG-TDP-35 variants (See Fig. 2a) overexpressed in HEK 293T
cells (Fig. 4). As observed previously [4], wild-type TDP-35 readily
formed inclusion bodies in cells (Fig. 4a). Mutation in RRM1 ofTDP-35 dramatically reduced the ability to form inclusions
(Fig. 4b), whereas mutation in RRM2 exhibited very little effect
on the inclusion formation (Fig. 4c). As expected, double-domain
mutation (4FL) led to almost total loss of the inclusions (Fig. 4d).
We statistically analyzed the percentages of the cell numbers with
inclusion bodies for these overexpressed TDP-35 types (Fig. 4e).
The data indicate that the ability to form inclusions in cells
Fig. 4. Binding with RNA is essential for the inclusion formation of TDP-35 in cells.
(a) Immunoﬂuorescence images showing inclusion formation in the HEK 293T cells
when overexpressed with wild-type FLAG-TDP-35. The cells were stained with
mouse anti-FLAG (green), and the nuclei were stained with DAPI (blue). Size
bar = 10 lm. (b) As in (a), with the M1 mutant. (c) As in (a), with the M2 mutant. (d)
As in (a), with the 4FL mutant. (e) Quantitation of the cells with inclusion bodies.
The inset shows equal expression level of the proteins. The inclusion bodies formed
in the HEK 293T cells that have been transfected with various FLAG-TDP-35 species
were counted and analyzed by one-way analysis of variance. n = 27–35; *P < 0.05;
**P < 0.01.
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RNA-binding ability, implying that RNA is not only essential for
formation of the TDP-35 inclusions, but also responsible for the
association of TDP-35 with TDP-43.
3.5. Poly(A)-containing RNAs are enriched in the TDP-35 inclusions
As demonstrated previously, TDP-35 could associate with
TDP-43 via RNAs. We speculated that TDP-35 may co-aggregate
with RNAs in cells. To deﬁne which kind of RNA existed in the cyto-
plasmic TDP-35 inclusions, we performed combined FISH and IF
experiments [24]. We used overexpressed GFP, a well diffused pro-
tein as a control, which can be detected with ﬂuorescence imaging
in HEK 293T cells. Meanwhile, different types of RNA were
detected with a Cy3 labeled probe (Fig. 5). In the cells overex-
pressed with GFP, 28S rRNA exhibited a dotted pattern in nucleolus
and a diffuse pattern in cytoplasm (Fig. 5a), while
poly(A)-containing RNAs detected with an oligo-dT probe largely
displayed in the nuclei and scarcely in the cytoplasm of
GFP-expressing cells (Fig. 5b). In the cells overexpressed with
FLAG-TDP-35 that can form cytoplasmic inclusions, 28S rRNA dis-
played a similar pattern as in the cells overexpressing GFP (Fig. 5c);
whereas poly(A)-containing RNAs were co-localized with the
inclusions formed by TDP-35 in cytoplasm (Fig. 5d). These
poly(A)-containing RNAs might have various species, such as
mRNA and long non-coding RNAs that contain poly(A) tails pre-
sented in the cytoplasm [31]. This observation implies that
poly(A)-containing RNAs but not 28S rRNA are enriched in the
TDP-35 inclusions, suggesting that these RNAs may participate in
formation of the cytoplasmic inclusion bodies.
3.6. The TDP-35 inclusions are dissociated more readily than the
typical protein aggregates
To further clarify the biochemical features of the TDP-35 inclu-
sions, we compared susceptibilities of the TDP-35 inclusions and
the typical protein aggregates to NP-40 treatment during cell lysis
by supernatant/pellet fractionation and ﬁlter-trap experiments.
TDPCT is the C-terminus of TDP-43 without RNA-binding ability
(Fig. 2a); while its GFP-fused form (GFP-TDPCT) readily aggregates
into insolubilities [4]. Compared with GFP-TDPCT that exhibited a
large amount of aggregates in the pellet fraction, both TDP-35 and
its 4FL mutant were mostly retained in the soluble fractions under
the same conditions of cell lysis. However, the pellet fraction of
TDP-35 was much smaller than that of GFP-TDPCT
(Fig. 6a and b), despite steady TDP-35 inclusions were observed
in cytoplasm (Fig. 4a) [4]. Moreover, the 4FL mutation signiﬁcantly
reduced the fraction of insoluble aggregates (Fig. 6a, inset). In a
ﬁlter-trap experiment, TDP-35 showed a much less amount of
aggregates retained in the ﬁlter than GFP-TDPCT under a condition
of NP-40 treatment (Fig. 6c), while the 4FL mutant only gave a
trace amount of aggregates. Interestingly, neither TDP-35 nor its
4FL mutant exhibited formation of SDS-resistant aggregates
(Fig. 6c, middle panel), but GFP-TDPCT did. Thus, the TDP-35 inclu-
sions that include RNAs are dissociated more readily than the typ-
ical GFP-TDPCT aggregates.
4. Discussion
TDP-43 is the major component of inclusion bodies in ALS and
FTLD patients [2]. Our previous work demonstrated that TDP-35,
a fragment of TDP-43, triggers cytoplasmic inclusions and causes
alteration of RNA processing [4], and the C-terminal amyloidogenic
core initiates its aggregation and formation of cytoplasmic inclu-
sions [32]. We have also revealed that TDP-35 sequesters normal
Fig. 5. Combined FISH and IF experiments showing that the cytoplasmic RNAs are enriched in the TDP-35 inclusions. (a) Confocal imaging detection of 28S rRNA with GFP as
a control. (b) Poly(A)-containing RNA with GFP. (c) 28S rRNA with FLAG-tagged TDP-35. (d) Poly(A)-containing RNA with FLAG-tagged TDP-35. GFP or FLAG-TDP-35 was
overexpressed in HEK 293T cells and then the 28S rRNA or poly(A)-containing RNA was detected by using the probes of 20-F RNA modiﬁed residues for FISH combined with IF.
GFP and FLAG-TDP-35 are green, RNAs are red, while the nuclei are blue (DAPI). Scale bar = 10 lm. (e) Quantitation of the TDP-35 aggregates co-localized with RNA. The
inclusion bodies formed by TDP-35 in the HEK 293T cells that co-aggregate with 28S rRNA in (c) and poly(A)-containing RNA in (d) were counted and analyzed by one-way
analysis of variance. n = 32–41; P < 0.05.
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RNAs play a critical role in their association. Thus, we propose that
this sequestration mediated by RNA is associated with the TDP-43
proteinopathy and potentially with neurodegeneration, as in the
case of the polyQ-expanded proteins that sequester cellular essen-
tial interacting partners into inclusions and lead to a
loss-of-function pathology [33].
TDP-43 contains two functionally important RNA-binding
domains. The role of the RRM domains in TDP-43 aggregation
has been studied in detail [17–19], suggesting that RNA binding
can inhibit TDP-43 aggregation in vitro [18]. The RRM1 moiety of
TDP-35 plays a dominant role in binding with RNA/DNA and medi-
ating association with TDP-43 [34], whereas RRM2may collaborate
with RRM1 to enhance the binding afﬁnities with nucleic acids
[30]. The tandem RRM domains in TDP-35 or TDP-43 cooperatively
facilitate formation of the TDP-35 inclusions and sequestration of
normal TDP-43 in cells. In addition, other RNA-binding proteins
may also be recruited into the inclusions via binding with various
RNAs [35,36].
We have shown that formation of the TDP-35 inclusions is facil-
itated by RNA binding. This is distinct from the insoluble proteinaggregates, formation of which is inhibited by TG-repeat nucleo-
tide binding in vitro [18]. We have also observed that TDP-25A, a
C-terminal fragment of TDP-43 containing only the RRM2 domain
that binds nucleic acids much more weakly than RRM1 [37], can-
not associate with TDP-43 either by RNA or synthesized ssDNA
(Fig. 1). Presumably, the TDP-35 inclusions mediated by RNA bind-
ing are relatively dynamic as compared with the insoluble aggre-
gates (Fig. 6). Because TDP-35 is capable of binding RNA and
forming inclusions that sequester full-length TDP-43 and other
RNPs, we speculate that the TDP-35 inclusions are something like
the so-called RNP granules [9,10], which are relatively dynamic
in cells.
Given that TDP-35 possesses most essential domains of TDP-43
but readily forms inclusions in cytoplasm, it might have some
impact on the inherent function of TDP-43 in mRNA processing
[4]. We have revealed that poly(A)-containing RNAs but not 28S
rRNA are enriched in the TDP-35 inclusions (Fig. 5). Although we
have not deﬁned the RNA species, there is still a possibility that
some speciﬁc RNAs, such as mRNA, 18S rRNA or microRNA, are also
included in the TDP-35 inclusions. There are accumulating evi-
dence supporting that the cellular stress granules package mRNA
Fig. 6. The TDP-35 inclusions are susceptible to dissociation. (a) Supernatant/pellet fractionation. The GFP-fused C-terminus of TDP-43 (GFP-TDPCT, residues 253–414),
which lost RNA-binding ability and formed typical insoluble aggregates, was set as a control. The lysates from transfected HEK 293T cells overexpressing indicated proteins
were fractionated into supernatant (Sup) and pellet (Pel) followed by immunoblotting against FLAG or GFP and actin. (b) Quantitation of the aggregate fraction in the pellets.
The pellet fractions were quantiﬁed, and the data were normalized and represented as Mean ± S.D. (n = 3); ***P < 0.001. (c) Filter trap analysis for detecting aggregates. The
pellets of the cell lysates were treated by mild (no SDS) condition (upper panel) or harsh (2% SDS and boiling for 5 min) condition (middle panel), and then subjected to ﬁlter
trap and Western blotting with an anti-GFP or FLAG antibody. The overexpression level of each protein was also shown.
M.-X. Che et al. / FEBS Letters 589 (2015) 1920–1928 1927and RNA-binding proteins for translational arrest during cell stress
[38]. TDP-35 was also reported to be co-stained with stress granule
markers such as poly(A)-binding protein and HuR in cytoplasm
[23]. In this aspect, the TDP-35 inclusions containing TDP-43 or
other RNPs formed by RNA-assisted sequestration could be
regarded as the cytoplasmic RNP granules, as the transportable
mRNA granules formed by TDP-43 [39] or stress granules [9,10],
which may be relevant to a gain-of-function pathology.
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